FINANCIAL AND OTHER RESOURCES
We can help identify the most appropriate assistance program to help you get access to ALECENSA® (alectinib).
You Might Qualify for a Referral to the Genentech BioOncology Co-pay Card
Genentech BioOncology® Access Solutions can refer you to the Genentech BioOncology Co-pay Card. It can help you with the out-of-pocket costs of your Genentech medicine, if you’re eligible.*
*In order to be eligible for the Genentech BioOncology Co-pay Card, the patient must have commercial insurance, must not have Medicare, Medicaid or other government insurance, and must meet other eligibility criteria. They also must agree to the rules set forth in the terms and conditions for the program. Please visit CopayAssistanceNow.com for the full list of terms and conditions.
You Might Qualify for a Referral to an Independent Co-pay Assistance Foundation
If you need help with your co-pay for your Genentech medicine, we can refer you to an independent co-pay assistance foundation.*
*Independent co-pay assistance foundations have their own rules for eligibility. We cannot guarantee a foundation will help you. We only can refer you to a foundation that supports your disease state. We do not endorse or show financial preference for any particular foundation. The foundations we refer you to are not the only ones that might be able to help you.
You Might Qualify for a Referral to the Genentech® Access to Care Foundation, or GATCF
GATCF can help you receive your Genentech medicine free of charge, if you qualify.*
*If you have health insurance, you must have already tried other types of patient assistance to qualify for free Genentech medicine from GATCF. This includes the Genentech BioOncology Co-pay Card and support from independent co-pay assistance foundations. You must also meet financial criteria. If you do not have insurance, you must meet different financial criteria.
Genentech BioOncology® Access Solutions for ALECENSA
If you are worried about paying for ALECENSA, we might be able to help. Assistance is available for eligible patients with commercial insurance (such as one you get through your employer), public insurance (such as Medicare or Medicaid) or no insurance.
Genentech offers the following options to help you pay for ALECENSA*:
|*||Genentech does not influence or control the operations or eligibility criteria of any co-pay assistance foundation and cannot guarantee co-pay assistance after a referral from Genentech BioOncology Access Solutions.|
|†||To be eligible for free medicine from GATCF, insured patients must have exhausted all other forms of patient assistance (including the Genentech BioOncology Co-pay Card and support from co-pay assistance foundations) and meet additional financial and medical criteria.|
|‡||To be eligible for the Genentech BioOncology Co-pay Card, patients must not have public insurance and must meet other criteria.|
To learn more about how we can help, contact us.
The Genentech BioOncology Co-pay Card
The Genentech BioOncology Co-pay Card may be able to help you with the out-of-pocket costs of your ALECENSA prescription. Those who qualify for the Genentech BioOncology Co-pay Card pay $25 per ALECENSA prescription. The annual benefit limit of the Co-pay Card is $25,000. There is no patient income requirement.
The Access Solutions logo is a registered trademark of Genentech, Inc. Genentech BioOncology® and its logo are registered trademarks of Genentech, Inc.
PATIENT SUPPORT LINE FOR ALECENSA
Speak live with one of our registered oncology nurses and get answers to your ALECENSA treatment questions.
1 (800) ALECENSA (253-2367)
Monday–Friday, 9am–9pm EST
Important Safety Information & Indication
Who Is ALECENSA For?
ALECENSA is a prescription medicine used to treat people with non-small cell lung cancer (NSCLC) that has spread to other parts of the body and:
- whose type of NSCLC is caused by an abnormal anaplastic lymphoma kinase (ALK) gene, and
- who have taken the medicine crizotinib, but their NSCLC worsened or they cannot tolerate taking crizotinib
It is not known if ALECENSA is safe and effective in children.
The effectiveness of ALECENSA in these patients is based on studies that measured 2 types of response to treatment (response rate and duration of response). There is an ongoing study to find out how ALECENSA works over a longer period of time.
What is the most important information I should know about ALECENSA?
Everyone reacts differently to treatment with ALECENSA. It’s important to know the most serious and most common side effects with ALECENSA.
Your doctor may lower the dose or stop treatment with ALECENSA if any side effects occur. Contact your doctor right away if you have any of the following side effects.
ALECENSA may cause serious side effects, including:
Liver problems (hepatotoxicity). ALECENSA may cause liver injury. Your doctor will do blood tests at least every 2 weeks for the first 3 months and then once a month and as needed during treatment with ALECENSA. Tell your doctor right away if you get any of the following signs and symptoms:
- Feeling tired
- Feeling less hungry than usual
- Yellowing of your skin or the whites of your eyes
- Dark urine
- Itchy skin
- Nausea or vomiting
- Pain on the right side of your stomach area
- Bleeding or bruising more easily than normal
Lung problems. ALECENSA may cause severe or life-threatening swelling (inflammation) of the lungs during treatment. Symptoms may be similar to those symptoms from lung cancer. Tell your doctor right away if you have any new or worsening symptoms, including:
- Trouble breathing
- Shortness of breath
Slow heartbeat (bradycardia). ALECENSA may cause very slow heartbeats that can be severe. Your doctor will check your heart rate and blood pressure during treatment with ALECENSA. Tell your doctor right away if you feel dizzy, lightheaded, or faint during treatment with ALECENSA. Tell your doctor if you take any heart or blood pressure medicines.
Muscle pain, tenderness, and weakness (myalgia). Muscle problems are common with ALECENSA and can be severe. Your doctor will do blood tests at least every 2 weeks for the first month and as needed during treatment with ALECENSA. Tell your doctor right away if you have any new or worsening signs and symptoms of muscle problems, including unexplained muscle pain or muscle pain that does not go away, tenderness, or weakness.
What should I tell my doctor before taking ALECENSA?
Before you take ALECENSA, tell your doctor about all of your medical conditions, including if you:
- Have liver problems
- Have lung or breathing problems
- Have a slow heartbeat
- Are pregnant or plan to become pregnant. ALECENSA can harm your unborn baby. Tell your doctor right away if you become pregnant during treatment with ALECENSA or think you may be pregnant
- Women who are able to become pregnant should use effective birth control during treatment with ALECENSA and for 1 week after the final dose of ALECENSA
- Men who have female partners that are able to become pregnant should use effective birth control during treatment with ALECENSA and for 3 months after the final dose of ALECENSA
- Are breastfeeding or plan to breastfeed. It is not known if ALECENSA passes into your breast milk. Do not breastfeed during treatment with ALECENSA and for 1 week after the final dose of ALECENSA. Talk to your doctor about the best way to feed your baby during this time
Tell your doctor about all the medicines you take, including prescription medicines, over-the-counter medicines, vitamins, and herbal supplements.
What should I avoid while taking ALECENSA?
Avoid spending time in the sunlight during treatment with ALECENSA and for 7 days after the final dose of ALECENSA. You may burn more easily and get severe sunburns. Use sunscreen and lip balm with a SPF 50 or greater to help protect against sunburn.
What are the possible side effects of ALECENSA?
The most common side effects of ALECENSA include:
- Swelling in your hands, feet, ankles, and eyelids
These are not all of the possible side effects of ALECENSA. For more information, ask your doctor or pharmacist. Call your doctor for medical advice about side effects.